Plerixafor Injection, Solution
Product Images NDC 72205-249

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 72205-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Plerixafor-injection-carton-label (Plerixafor Injection Carton Label)

The unfolded carton label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) by Novadoz Pharmaceuticals LLC. The label specifies it is for subcutaneous injection, single-dose vial, with storage and ingredient information. The manufacturer is MSN Laboratories Private Limited, India, with product and barcode information visible.*

FDA Label Image

Plerixafor-injection-vial-label (Plerixafor Injection Vial Label)

Label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) solution for subcutaneous injection. Distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Manufactured by MSN Laboratories Private Limited, Telangana, India. Includes a barcode, NDC 72205-249-01, and issuance date of 05/2023.*

FDA Label Image

Plerixafor-structure (Plerixafor Structure)

Chemical structure diagram of plerixafor showing its molecular framework with nitrogen-containing ring systems and a benzene ring, representing the active ingredient plerixafor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.